Clinical trial

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in…

NCT00190606 · Eli Lilly and Company, Industry · Completed

Key facts

NCT number NCT00190606
Title Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence
Official title Efficacy and Safety of Duloxetine Compared With Placebo,Pelvic Floor Muscle Training, and Combined Duloxetine/Pelvic Floor Muscle Training in Subjects With Moderate to Sever Stress Urinary Incontinence
Lead sponsor Eli Lilly and Company, Industry
Collaborators Boehringer Ingelheim Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Urinary Stress Incontinence
Intervention type Drug, Procedure
Interventions Duloxetine, Pelvic Floor Muscle Training (PFMT), Imitation PFMT, placebo
Enrollment 200
Start date Jan 1, 2002
Completion Apr 1, 2006
First posted Sep 19, 2005
Last update posted Jan 26, 2007
Countries Netherlands, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies